Biodefense Market
Biodefense Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Biodefense Market Size and Growth
The global biodefense market is projected to experience steady growth due to increasing government investments in bioterrorism prevention and response. Market size is estimated at $11.6 billion in 2020, with North America dominating the market. Factors such as technological advancements and growing threat of bioterrorism are driving market expansion. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Emergent Biosolutions
◍ Hytest
◍ GSK
◍ Sanofi
◍ PharmAthene
◍ Bavarian Nordic
◍ SIGA Technologies
◍ Arbutus Biopharma
◍ DynPort Vaccine
◍ Xoma Corporation
◍ Ichor Medical Systems
◍ Aeolus Pharmaceuticals
◍ Achaogen
◍ Elusys Therapeutics
◍ Dynavax Technologies
◍ Cleveland BioLabs
◍ Soligenix
◍ Alnylam Pharmaceuticals
The Biodefense Market is highly competitive with key players such as Emergent Biosolutions, GSK, Sanofi, and DynPort Vaccine. These companies develop vaccines, therapeutics, and diagnostic tools for bioterrorism threats. Sales revenue of some companies: Emergent Biosolutions ($1.09B), GSK ($11.96B), Sanofi ($37.59B). They play a crucial role in growing the Biodefense Market by offering innovative solutions to combat biothreats.
Request Sample Report
Market Segmentation
By Application
◍ US Military Market
◍ US Civilian Market
◍ Non - US Market
By Product
◍ Anthrax
◍ Smallpox
◍ Botulism
◍ Radiation/Nuclear
◍ Others
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients